215 related articles for article (PubMed ID: 1725631)
21. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of screening and complementary tests for anti-HCV antibodies].
Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
24. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
[TBL] [Abstract][Full Text] [Related]
25. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS].
Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M
Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
[TBL] [Abstract][Full Text] [Related]
27. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
Zenz W; Hofmann H; Muntean W
Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
32. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
[No Abstract] [Full Text] [Related]
33. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
34. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
Janot C
Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
[No Abstract] [Full Text] [Related]
35. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
[TBL] [Abstract][Full Text] [Related]
37. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
[TBL] [Abstract][Full Text] [Related]
38. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of hepatitis C virus infection in a population of drug addicts and their heterosexual partners].
Vannucci P; Dei A; Moncini C; Corti F; Boffoli M; Cancellotti F; Pesola A
Minerva Med; 1992 May; 83(5):265-7. PubMed ID: 1317020
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
